Global Facial Injections

Facial Injections Comprehensive Study by Type (Hyaluronic Acid Wrinkle Fillers, Synthetic Wrinkle Fillers, Collagen Wrinkle Fillers, Autologous Wrinkle Fillers), Application (Facial line correction, Lip augmentation, Facelift, Others), End users (Hospitals, Dermatology Clinics, Beauty Clinics, Dermatology Research Institutes) Players and Region - Global Market Outlook to 2030

Facial Injections Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 12.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Facial Injections
According to the WHO in 2018, there is a growing anti-ageing population demanding for skin rejuvenation over past few years. Hence, creating a huge demand for facial injections over the forecast period. Facial fillers or Injectables are products such as calcium hydroxyl apatite, collagen, hyaluronic acid helps to rejuvenate facial skin by reducing or eliminating wrinkles, enhancing lips and replacing soft-tissue volume loss by using facial injections. Further, rising demand to enhance the aesthetic beauty and growing preference for minimally invasive procedures, increase in pool of geriatric population and introduction of better facial injectable are factors propelling the market growth.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR12.3%


The Global facial injections market is fragmented with several players present in the market who are making collaborations and product launch strategies in order to address the unmet aesthetic needs. Thereby, providing the physicians with new and better options, as well as augmenting the growth of the facial Injection market. The companies are also focusing on expanding their presence in the emerging markets and also trying to maintain strong distributor relationships. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Facial Injections market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Allergan (Republic of Ireland), Galdermal (Q-Med) (Switzerland), Dr. Korman Laboratories (Israel), Integra Lifesciences (United States), Merz Pharma (Germany), Sinclair Pharma (United Kingdom), Sanofi Aventis (France) and Bohus BioTech (Sweden) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Teoxane laboratories (Switzerland), IMEIK (China), Bloomage Freda (China), Sinclair Pharma (United Kingdom) and Merz Pharma (Germany).

Segmentation Overview
AMA Research has segmented the market of Global Facial Injections market by Type (Hyaluronic Acid Wrinkle Fillers, Synthetic Wrinkle Fillers, Collagen Wrinkle Fillers and Autologous Wrinkle Fillers), Application (Facial line correction, Lip augmentation, Facelift and Others) and Region.



On the basis of geography, the market of Facial Injections has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End users, the sub-segment i.e. Hospitals will boost the Facial Injections market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Owing to Less Recovery Time period and Minimal Invasive Surgeries and Launch of Synthetic Calcium Hydroxyl Apatite Fillers

Market Growth Drivers:
Rising Disposable Income & Changing Lifestyle among Consumers, Emerging Physical Appearance Obsessions and Increasing Frequency of Facial Surgeries in the Coming Years

Challenges:
Stringent Government Regulations is posing a Challenge for the market

Restraints:
High Cost of Facial Surgeries and Side Effects Experienced by the Consumers may hinder the Market Growth

Opportunities:
Increasing Investment in the Healthcare Sector and Increasing use of Facial Injectables in the Cosmetic Industry

Market Leaders and their expansionary development strategies
In February 2023, Allergan, a leading manufacturer of Botox and Juvederm, announced its acquisition of Evolus, a company specializing in long-lasting neuromodulators. This merger aims to strengthen Allergan's position in the injectable aesthetics market.
In March 2023, Merz Aesthetics introduced Belotero Rejuvenate, a new filler designed for subtle facial rejuvenation and hydration. This product targets a growing trend towards natural-looking enhancements.
In 2017, FDA approved hyaluronic acid made facial injection named JUVEDERM VOLLURE XC which treats the moderate to severe facial wrinkles and folds in adults over the age of 21. Botulinum toxin, normally referred to as botox facial injections held the second largest market share and anticipated to surge further over the forecast period.

Key Target Audience
Facial Injection Manufacturers, Facial Injection Potential Investors, Industry Associations, Marketing firms, Downstream Vendors, Government and Regulatory Bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Hyaluronic Acid Wrinkle Fillers
  • Synthetic Wrinkle Fillers
  • Collagen Wrinkle Fillers
  • Autologous Wrinkle Fillers
By Application
  • Facial line correction
  • Lip augmentation
  • Facelift
  • Others
By End users
  • Hospitals
  • Dermatology Clinics
  • Beauty Clinics
  • Dermatology Research Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Disposable Income & Changing Lifestyle among Consumers
      • 3.2.2. Emerging Physical Appearance Obsessions
      • 3.2.3. Increasing Frequency of Facial Surgeries in the Coming Years
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Regulations is posing a Challenge for the market
    • 3.4. Market Trends
      • 3.4.1. Owing to Less Recovery Time period and Minimal Invasive Surgeries
      • 3.4.2. Launch of Synthetic Calcium Hydroxyl Apatite Fillers
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Facial Injections, by Type, Application, End users and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Facial Injections (Value)
      • 5.2.1. Global Facial Injections by: Type (Value)
        • 5.2.1.1. Hyaluronic Acid Wrinkle Fillers
        • 5.2.1.2. Synthetic Wrinkle Fillers
        • 5.2.1.3. Collagen Wrinkle Fillers
        • 5.2.1.4. Autologous Wrinkle Fillers
      • 5.2.2. Global Facial Injections by: Application (Value)
        • 5.2.2.1. Facial line correction
        • 5.2.2.2. Lip augmentation
        • 5.2.2.3. Facelift
        • 5.2.2.4. Others
      • 5.2.3. Global Facial Injections by: End users (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Dermatology Clinics
        • 5.2.3.3. Beauty Clinics
        • 5.2.3.4. Dermatology Research Institutes
      • 5.2.4. Global Facial Injections Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Facial Injections: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Allergan (Republic of Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Galdermal (Q-Med) (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Dr. Korman Laboratories (Israel)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Integra Lifesciences (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merz Pharma (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sinclair Pharma (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sanofi Aventis (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bohus BioTech (Sweden)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Facial Injections Sale, by Type, Application, End users and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Facial Injections (Value)
      • 7.2.1. Global Facial Injections by: Type (Value)
        • 7.2.1.1. Hyaluronic Acid Wrinkle Fillers
        • 7.2.1.2. Synthetic Wrinkle Fillers
        • 7.2.1.3. Collagen Wrinkle Fillers
        • 7.2.1.4. Autologous Wrinkle Fillers
      • 7.2.2. Global Facial Injections by: Application (Value)
        • 7.2.2.1. Facial line correction
        • 7.2.2.2. Lip augmentation
        • 7.2.2.3. Facelift
        • 7.2.2.4. Others
      • 7.2.3. Global Facial Injections by: End users (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Dermatology Clinics
        • 7.2.3.3. Beauty Clinics
        • 7.2.3.4. Dermatology Research Institutes
      • 7.2.4. Global Facial Injections Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Facial Injections: by Type(USD Million)
  • Table 2. Facial Injections Hyaluronic Acid Wrinkle Fillers , by Region USD Million (2018-2023)
  • Table 3. Facial Injections Synthetic Wrinkle Fillers , by Region USD Million (2018-2023)
  • Table 4. Facial Injections Collagen Wrinkle Fillers , by Region USD Million (2018-2023)
  • Table 5. Facial Injections Autologous Wrinkle Fillers , by Region USD Million (2018-2023)
  • Table 6. Facial Injections: by Application(USD Million)
  • Table 7. Facial Injections Facial line correction , by Region USD Million (2018-2023)
  • Table 8. Facial Injections Lip augmentation , by Region USD Million (2018-2023)
  • Table 9. Facial Injections Facelift , by Region USD Million (2018-2023)
  • Table 10. Facial Injections Others , by Region USD Million (2018-2023)
  • Table 11. Facial Injections: by End users(USD Million)
  • Table 12. Facial Injections Hospitals , by Region USD Million (2018-2023)
  • Table 13. Facial Injections Dermatology Clinics , by Region USD Million (2018-2023)
  • Table 14. Facial Injections Beauty Clinics , by Region USD Million (2018-2023)
  • Table 15. Facial Injections Dermatology Research Institutes , by Region USD Million (2018-2023)
  • Table 16. South America Facial Injections, by Country USD Million (2018-2023)
  • Table 17. South America Facial Injections, by Type USD Million (2018-2023)
  • Table 18. South America Facial Injections, by Application USD Million (2018-2023)
  • Table 19. South America Facial Injections, by End users USD Million (2018-2023)
  • Table 20. Brazil Facial Injections, by Type USD Million (2018-2023)
  • Table 21. Brazil Facial Injections, by Application USD Million (2018-2023)
  • Table 22. Brazil Facial Injections, by End users USD Million (2018-2023)
  • Table 23. Argentina Facial Injections, by Type USD Million (2018-2023)
  • Table 24. Argentina Facial Injections, by Application USD Million (2018-2023)
  • Table 25. Argentina Facial Injections, by End users USD Million (2018-2023)
  • Table 26. Rest of South America Facial Injections, by Type USD Million (2018-2023)
  • Table 27. Rest of South America Facial Injections, by Application USD Million (2018-2023)
  • Table 28. Rest of South America Facial Injections, by End users USD Million (2018-2023)
  • Table 29. Asia Pacific Facial Injections, by Country USD Million (2018-2023)
  • Table 30. Asia Pacific Facial Injections, by Type USD Million (2018-2023)
  • Table 31. Asia Pacific Facial Injections, by Application USD Million (2018-2023)
  • Table 32. Asia Pacific Facial Injections, by End users USD Million (2018-2023)
  • Table 33. China Facial Injections, by Type USD Million (2018-2023)
  • Table 34. China Facial Injections, by Application USD Million (2018-2023)
  • Table 35. China Facial Injections, by End users USD Million (2018-2023)
  • Table 36. Japan Facial Injections, by Type USD Million (2018-2023)
  • Table 37. Japan Facial Injections, by Application USD Million (2018-2023)
  • Table 38. Japan Facial Injections, by End users USD Million (2018-2023)
  • Table 39. India Facial Injections, by Type USD Million (2018-2023)
  • Table 40. India Facial Injections, by Application USD Million (2018-2023)
  • Table 41. India Facial Injections, by End users USD Million (2018-2023)
  • Table 42. South Korea Facial Injections, by Type USD Million (2018-2023)
  • Table 43. South Korea Facial Injections, by Application USD Million (2018-2023)
  • Table 44. South Korea Facial Injections, by End users USD Million (2018-2023)
  • Table 45. Taiwan Facial Injections, by Type USD Million (2018-2023)
  • Table 46. Taiwan Facial Injections, by Application USD Million (2018-2023)
  • Table 47. Taiwan Facial Injections, by End users USD Million (2018-2023)
  • Table 48. Australia Facial Injections, by Type USD Million (2018-2023)
  • Table 49. Australia Facial Injections, by Application USD Million (2018-2023)
  • Table 50. Australia Facial Injections, by End users USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Facial Injections, by Type USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Facial Injections, by Application USD Million (2018-2023)
  • Table 53. Rest of Asia-Pacific Facial Injections, by End users USD Million (2018-2023)
  • Table 54. Europe Facial Injections, by Country USD Million (2018-2023)
  • Table 55. Europe Facial Injections, by Type USD Million (2018-2023)
  • Table 56. Europe Facial Injections, by Application USD Million (2018-2023)
  • Table 57. Europe Facial Injections, by End users USD Million (2018-2023)
  • Table 58. Germany Facial Injections, by Type USD Million (2018-2023)
  • Table 59. Germany Facial Injections, by Application USD Million (2018-2023)
  • Table 60. Germany Facial Injections, by End users USD Million (2018-2023)
  • Table 61. France Facial Injections, by Type USD Million (2018-2023)
  • Table 62. France Facial Injections, by Application USD Million (2018-2023)
  • Table 63. France Facial Injections, by End users USD Million (2018-2023)
  • Table 64. Italy Facial Injections, by Type USD Million (2018-2023)
  • Table 65. Italy Facial Injections, by Application USD Million (2018-2023)
  • Table 66. Italy Facial Injections, by End users USD Million (2018-2023)
  • Table 67. United Kingdom Facial Injections, by Type USD Million (2018-2023)
  • Table 68. United Kingdom Facial Injections, by Application USD Million (2018-2023)
  • Table 69. United Kingdom Facial Injections, by End users USD Million (2018-2023)
  • Table 70. Netherlands Facial Injections, by Type USD Million (2018-2023)
  • Table 71. Netherlands Facial Injections, by Application USD Million (2018-2023)
  • Table 72. Netherlands Facial Injections, by End users USD Million (2018-2023)
  • Table 73. Rest of Europe Facial Injections, by Type USD Million (2018-2023)
  • Table 74. Rest of Europe Facial Injections, by Application USD Million (2018-2023)
  • Table 75. Rest of Europe Facial Injections, by End users USD Million (2018-2023)
  • Table 76. MEA Facial Injections, by Country USD Million (2018-2023)
  • Table 77. MEA Facial Injections, by Type USD Million (2018-2023)
  • Table 78. MEA Facial Injections, by Application USD Million (2018-2023)
  • Table 79. MEA Facial Injections, by End users USD Million (2018-2023)
  • Table 80. Middle East Facial Injections, by Type USD Million (2018-2023)
  • Table 81. Middle East Facial Injections, by Application USD Million (2018-2023)
  • Table 82. Middle East Facial Injections, by End users USD Million (2018-2023)
  • Table 83. Africa Facial Injections, by Type USD Million (2018-2023)
  • Table 84. Africa Facial Injections, by Application USD Million (2018-2023)
  • Table 85. Africa Facial Injections, by End users USD Million (2018-2023)
  • Table 86. North America Facial Injections, by Country USD Million (2018-2023)
  • Table 87. North America Facial Injections, by Type USD Million (2018-2023)
  • Table 88. North America Facial Injections, by Application USD Million (2018-2023)
  • Table 89. North America Facial Injections, by End users USD Million (2018-2023)
  • Table 90. United States Facial Injections, by Type USD Million (2018-2023)
  • Table 91. United States Facial Injections, by Application USD Million (2018-2023)
  • Table 92. United States Facial Injections, by End users USD Million (2018-2023)
  • Table 93. Canada Facial Injections, by Type USD Million (2018-2023)
  • Table 94. Canada Facial Injections, by Application USD Million (2018-2023)
  • Table 95. Canada Facial Injections, by End users USD Million (2018-2023)
  • Table 96. Mexico Facial Injections, by Type USD Million (2018-2023)
  • Table 97. Mexico Facial Injections, by Application USD Million (2018-2023)
  • Table 98. Mexico Facial Injections, by End users USD Million (2018-2023)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Facial Injections: by Type(USD Million)
  • Table 108. Facial Injections Hyaluronic Acid Wrinkle Fillers , by Region USD Million (2025-2030)
  • Table 109. Facial Injections Synthetic Wrinkle Fillers , by Region USD Million (2025-2030)
  • Table 110. Facial Injections Collagen Wrinkle Fillers , by Region USD Million (2025-2030)
  • Table 111. Facial Injections Autologous Wrinkle Fillers , by Region USD Million (2025-2030)
  • Table 112. Facial Injections: by Application(USD Million)
  • Table 113. Facial Injections Facial line correction , by Region USD Million (2025-2030)
  • Table 114. Facial Injections Lip augmentation , by Region USD Million (2025-2030)
  • Table 115. Facial Injections Facelift , by Region USD Million (2025-2030)
  • Table 116. Facial Injections Others , by Region USD Million (2025-2030)
  • Table 117. Facial Injections: by End users(USD Million)
  • Table 118. Facial Injections Hospitals , by Region USD Million (2025-2030)
  • Table 119. Facial Injections Dermatology Clinics , by Region USD Million (2025-2030)
  • Table 120. Facial Injections Beauty Clinics , by Region USD Million (2025-2030)
  • Table 121. Facial Injections Dermatology Research Institutes , by Region USD Million (2025-2030)
  • Table 122. South America Facial Injections, by Country USD Million (2025-2030)
  • Table 123. South America Facial Injections, by Type USD Million (2025-2030)
  • Table 124. South America Facial Injections, by Application USD Million (2025-2030)
  • Table 125. South America Facial Injections, by End users USD Million (2025-2030)
  • Table 126. Brazil Facial Injections, by Type USD Million (2025-2030)
  • Table 127. Brazil Facial Injections, by Application USD Million (2025-2030)
  • Table 128. Brazil Facial Injections, by End users USD Million (2025-2030)
  • Table 129. Argentina Facial Injections, by Type USD Million (2025-2030)
  • Table 130. Argentina Facial Injections, by Application USD Million (2025-2030)
  • Table 131. Argentina Facial Injections, by End users USD Million (2025-2030)
  • Table 132. Rest of South America Facial Injections, by Type USD Million (2025-2030)
  • Table 133. Rest of South America Facial Injections, by Application USD Million (2025-2030)
  • Table 134. Rest of South America Facial Injections, by End users USD Million (2025-2030)
  • Table 135. Asia Pacific Facial Injections, by Country USD Million (2025-2030)
  • Table 136. Asia Pacific Facial Injections, by Type USD Million (2025-2030)
  • Table 137. Asia Pacific Facial Injections, by Application USD Million (2025-2030)
  • Table 138. Asia Pacific Facial Injections, by End users USD Million (2025-2030)
  • Table 139. China Facial Injections, by Type USD Million (2025-2030)
  • Table 140. China Facial Injections, by Application USD Million (2025-2030)
  • Table 141. China Facial Injections, by End users USD Million (2025-2030)
  • Table 142. Japan Facial Injections, by Type USD Million (2025-2030)
  • Table 143. Japan Facial Injections, by Application USD Million (2025-2030)
  • Table 144. Japan Facial Injections, by End users USD Million (2025-2030)
  • Table 145. India Facial Injections, by Type USD Million (2025-2030)
  • Table 146. India Facial Injections, by Application USD Million (2025-2030)
  • Table 147. India Facial Injections, by End users USD Million (2025-2030)
  • Table 148. South Korea Facial Injections, by Type USD Million (2025-2030)
  • Table 149. South Korea Facial Injections, by Application USD Million (2025-2030)
  • Table 150. South Korea Facial Injections, by End users USD Million (2025-2030)
  • Table 151. Taiwan Facial Injections, by Type USD Million (2025-2030)
  • Table 152. Taiwan Facial Injections, by Application USD Million (2025-2030)
  • Table 153. Taiwan Facial Injections, by End users USD Million (2025-2030)
  • Table 154. Australia Facial Injections, by Type USD Million (2025-2030)
  • Table 155. Australia Facial Injections, by Application USD Million (2025-2030)
  • Table 156. Australia Facial Injections, by End users USD Million (2025-2030)
  • Table 157. Rest of Asia-Pacific Facial Injections, by Type USD Million (2025-2030)
  • Table 158. Rest of Asia-Pacific Facial Injections, by Application USD Million (2025-2030)
  • Table 159. Rest of Asia-Pacific Facial Injections, by End users USD Million (2025-2030)
  • Table 160. Europe Facial Injections, by Country USD Million (2025-2030)
  • Table 161. Europe Facial Injections, by Type USD Million (2025-2030)
  • Table 162. Europe Facial Injections, by Application USD Million (2025-2030)
  • Table 163. Europe Facial Injections, by End users USD Million (2025-2030)
  • Table 164. Germany Facial Injections, by Type USD Million (2025-2030)
  • Table 165. Germany Facial Injections, by Application USD Million (2025-2030)
  • Table 166. Germany Facial Injections, by End users USD Million (2025-2030)
  • Table 167. France Facial Injections, by Type USD Million (2025-2030)
  • Table 168. France Facial Injections, by Application USD Million (2025-2030)
  • Table 169. France Facial Injections, by End users USD Million (2025-2030)
  • Table 170. Italy Facial Injections, by Type USD Million (2025-2030)
  • Table 171. Italy Facial Injections, by Application USD Million (2025-2030)
  • Table 172. Italy Facial Injections, by End users USD Million (2025-2030)
  • Table 173. United Kingdom Facial Injections, by Type USD Million (2025-2030)
  • Table 174. United Kingdom Facial Injections, by Application USD Million (2025-2030)
  • Table 175. United Kingdom Facial Injections, by End users USD Million (2025-2030)
  • Table 176. Netherlands Facial Injections, by Type USD Million (2025-2030)
  • Table 177. Netherlands Facial Injections, by Application USD Million (2025-2030)
  • Table 178. Netherlands Facial Injections, by End users USD Million (2025-2030)
  • Table 179. Rest of Europe Facial Injections, by Type USD Million (2025-2030)
  • Table 180. Rest of Europe Facial Injections, by Application USD Million (2025-2030)
  • Table 181. Rest of Europe Facial Injections, by End users USD Million (2025-2030)
  • Table 182. MEA Facial Injections, by Country USD Million (2025-2030)
  • Table 183. MEA Facial Injections, by Type USD Million (2025-2030)
  • Table 184. MEA Facial Injections, by Application USD Million (2025-2030)
  • Table 185. MEA Facial Injections, by End users USD Million (2025-2030)
  • Table 186. Middle East Facial Injections, by Type USD Million (2025-2030)
  • Table 187. Middle East Facial Injections, by Application USD Million (2025-2030)
  • Table 188. Middle East Facial Injections, by End users USD Million (2025-2030)
  • Table 189. Africa Facial Injections, by Type USD Million (2025-2030)
  • Table 190. Africa Facial Injections, by Application USD Million (2025-2030)
  • Table 191. Africa Facial Injections, by End users USD Million (2025-2030)
  • Table 192. North America Facial Injections, by Country USD Million (2025-2030)
  • Table 193. North America Facial Injections, by Type USD Million (2025-2030)
  • Table 194. North America Facial Injections, by Application USD Million (2025-2030)
  • Table 195. North America Facial Injections, by End users USD Million (2025-2030)
  • Table 196. United States Facial Injections, by Type USD Million (2025-2030)
  • Table 197. United States Facial Injections, by Application USD Million (2025-2030)
  • Table 198. United States Facial Injections, by End users USD Million (2025-2030)
  • Table 199. Canada Facial Injections, by Type USD Million (2025-2030)
  • Table 200. Canada Facial Injections, by Application USD Million (2025-2030)
  • Table 201. Canada Facial Injections, by End users USD Million (2025-2030)
  • Table 202. Mexico Facial Injections, by Type USD Million (2025-2030)
  • Table 203. Mexico Facial Injections, by Application USD Million (2025-2030)
  • Table 204. Mexico Facial Injections, by End users USD Million (2025-2030)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Facial Injections: by Type USD Million (2018-2023)
  • Figure 5. Global Facial Injections: by Application USD Million (2018-2023)
  • Figure 6. Global Facial Injections: by End users USD Million (2018-2023)
  • Figure 7. South America Facial Injections Share (%), by Country
  • Figure 8. Asia Pacific Facial Injections Share (%), by Country
  • Figure 9. Europe Facial Injections Share (%), by Country
  • Figure 10. MEA Facial Injections Share (%), by Country
  • Figure 11. North America Facial Injections Share (%), by Country
  • Figure 12. Global Facial Injections share by Players 2023 (%)
  • Figure 13. Global Facial Injections share by Players (Top 3) 2023(%)
  • Figure 14. Global Facial Injections share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Allergan (Republic of Ireland) Revenue, Net Income and Gross profit
  • Figure 17. Allergan (Republic of Ireland) Revenue: by Geography 2023
  • Figure 18. Galdermal (Q-Med) (Switzerland) Revenue, Net Income and Gross profit
  • Figure 19. Galdermal (Q-Med) (Switzerland) Revenue: by Geography 2023
  • Figure 20. Dr. Korman Laboratories (Israel) Revenue, Net Income and Gross profit
  • Figure 21. Dr. Korman Laboratories (Israel) Revenue: by Geography 2023
  • Figure 22. Integra Lifesciences (United States) Revenue, Net Income and Gross profit
  • Figure 23. Integra Lifesciences (United States) Revenue: by Geography 2023
  • Figure 24. Merz Pharma (Germany) Revenue, Net Income and Gross profit
  • Figure 25. Merz Pharma (Germany) Revenue: by Geography 2023
  • Figure 26. Sinclair Pharma (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. Sinclair Pharma (United Kingdom) Revenue: by Geography 2023
  • Figure 28. Sanofi Aventis (France) Revenue, Net Income and Gross profit
  • Figure 29. Sanofi Aventis (France) Revenue: by Geography 2023
  • Figure 30. Bohus BioTech (Sweden) Revenue, Net Income and Gross profit
  • Figure 31. Bohus BioTech (Sweden) Revenue: by Geography 2023
  • Figure 32. Global Facial Injections: by Type USD Million (2025-2030)
  • Figure 33. Global Facial Injections: by Application USD Million (2025-2030)
  • Figure 34. Global Facial Injections: by End users USD Million (2025-2030)
  • Figure 35. South America Facial Injections Share (%), by Country
  • Figure 36. Asia Pacific Facial Injections Share (%), by Country
  • Figure 37. Europe Facial Injections Share (%), by Country
  • Figure 38. MEA Facial Injections Share (%), by Country
  • Figure 39. North America Facial Injections Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Allergan (Republic of Ireland)
  • Galdermal (Q-Med) (Switzerland)
  • Dr. Korman Laboratories (Israel)
  • Integra Lifesciences (United States)
  • Merz Pharma (Germany)
  • Sinclair Pharma (United Kingdom)
  • Sanofi Aventis (France)
  • Bohus BioTech (Sweden)
Additional players considered in the study are as follows:
Teoxane laboratories (Switzerland) , IMEIK (China) , Bloomage Freda (China) , Sinclair Pharma (United Kingdom) , Merz Pharma (Germany)
Select User Access Type

Key Highlights of Report


Jan 2024 231 Pages 60 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Facial Injections Quantitative research analysis
Global Facial Injections Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Allergan (Republic of Ireland), Galdermal (Q-Med) (Switzerland), Dr. Korman Laboratories (Israel), Integra Lifesciences (United States), Merz Pharma (Germany), Sinclair Pharma (United Kingdom), Sanofi Aventis (France) and Bohus BioTech (Sweden) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Owing to Less Recovery Time period and Minimal Invasive Surgeries " is seen as one of major influencing trends for Facial Injections Market during projected period 2023-2030.
The Facial Injections market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Facial Injections Report?

Have a Query? Click Here

Other Related Reports

Medical Adhesives Comprehensive Study by Type (Water Type, Solvent Type, Solids & Hot Melt Type, Others), Application (Medical Device & Equipment, Internal Medical, External Medical, Dental, Others),...
$ 3650
Surgical Gloves Comprehensive Study by Type (Natural Latex Surgical gloves, Non-Latex Surgical gloves), Application (Hospitals, Pharmacy stores, Research Laboratories, Food and Beverages Industry, Ot...
$ 3750
Medical Refrigerator Comprehensive Study by Type (Plasma Freezers, Blood Bank Refrigerators, Lab Refrigerators, Ultra Low Temperature Freezers, Shock Freezers), Application (Hospital, Blood Bank, Pha...
$ 3750
Hemodialysis Concentrates Comprehensive Study by Type (Acid Concentrates, Bicarbonate Concentrates), Application (Dialysis Center, Home), Form (Powder, Solution), Distribution Channel (Direct Sales, ...
$ 3500
Medical Furniture Comprehensive Study by Type (Beds, Chairs, Trolleys &Stretchers, Tables, Cabinets &Lockers, Operating Tables, Others), Application (Home, Clinic, Hospital), Distribution Channel (Di...
$ 3750
Humira Comprehensive Study by Type (Humira Syringe, Humira Pen), Application (Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn's Disease, Other), Sales Channel (OTC Drugs, Prescription Based Drugs...
$ 3500